David Casley

3.5k total citations
88 papers, 2.9k citations indexed

About

David Casley is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David Casley has authored 88 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 30 papers in Molecular Biology and 26 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David Casley's work include Renin-Angiotensin System Studies (30 papers), Nitric Oxide and Endothelin Effects (22 papers) and Receptor Mechanisms and Signaling (21 papers). David Casley is often cited by papers focused on Renin-Angiotensin System Studies (30 papers), Nitric Oxide and Endothelin Effects (22 papers) and Receptor Mechanisms and Signaling (21 papers). David Casley collaborates with scholars based in Australia, Japan and United States. David Casley's co-authors include Colin I. Johnston, Mark E. Cooper, Siew Yeen Chai, Winifred G. Nayler, Masahiro Kohzuki, Darren J. Kelly, Mark E. Cooper, Zemin Cao, Rachael Dean and Frederick A.O. Mendelsohn and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and The Journal of Physiology.

In The Last Decade

David Casley

88 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Casley Australia	31	1.5k	937	786	775	350	88	2.9k
Sandford L. Skinner Australia	33	1.8k 1.3×	1.1k 1.1×	638 0.8×	1.0k 1.3×	509 1.5×	93	4.1k
Ole Skøtt Denmark	36	1.4k 0.9×	1.8k 1.9×	838 1.1×	976 1.3×	588 1.7×	118	3.9k
Pernille Hansen Denmark	34	961 0.7×	1.4k 1.5×	724 0.9×	694 0.9×	369 1.1×	107	3.1k
Ryoji Ozono Japan	29	1.6k 1.1×	1.1k 1.1×	468 0.6×	936 1.2×	132 0.4×	92	2.9k
Yoshiyuki Toya Japan	31	1.1k 0.8×	1.4k 1.4×	424 0.5×	531 0.7×	262 0.7×	143	3.2k
Frank Schweda Germany	39	1.4k 1.0×	1.9k 2.1×	623 0.8×	1.0k 1.3×	626 1.8×	111	4.2k
Kiyoko Naruse Japan	31	1.4k 1.0×	903 1.0×	681 0.9×	833 1.1×	90 0.3×	116	2.8k
Kazuo Kanno Japan	25	979 0.7×	1.0k 1.1×	1.7k 2.1×	428 0.6×	212 0.6×	40	3.0k
Leonard G. Meggs United States	26	1.7k 1.2×	1.3k 1.4×	327 0.4×	453 0.6×	305 0.9×	60	3.1k
Paul C. Churchill United States	28	867 0.6×	797 0.9×	431 0.5×	326 0.4×	423 1.2×	107	2.3k

Countries citing papers authored by David Casley

Since Specialization

Citations

This map shows the geographic impact of David Casley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Casley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Casley more than expected).

Fields of papers citing papers by David Casley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Casley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Casley. The network helps show where David Casley may publish in the future.

Co-authorship network of co-authors of David Casley

This figure shows the co-authorship network connecting the top 25 collaborators of David Casley. A scholar is included among the top collaborators of David Casley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Casley. David Casley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Herath, Chandana B., John Lubel, Zhiyuan Jia, et al.. (2009). Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2. American Journal of Physiology-Gastrointestinal and Liver Physiology. 297(1). G98–G106. 31 indexed citations

Tikellis, Christos, et al.. (2003). Calcitonin receptor isoforms expressed in the developing rat kidney. Kidney International. 63(2). 416–426. 30 indexed citations

Tikellis, Christos, Jillian Craigie, David Casley, et al.. (2003). Novel hexad repeats conserved in a putative transporter with restricted expression in cell types associated with growth, calcium exchange and homeostasis. Experimental Cell Research. 293(1). 31–42. 18 indexed citations

Bonnet, Fabrice, Mark E. Cooper, Robert M. Carey, David Casley, & Zemin Cao. (2001). Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion. Journal of Hypertension. 19(6). 1075–1081. 54 indexed citations

Hubner, Richard, Eiji Kubota, David Casley, Colin I. Johnston, & Louise M. Burrell. (2001). In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat. Journal of Hypertension. 19(5). 941–946. 18 indexed citations

Wookey, Peter J., et al.. (1998). Amylin as a growth factor during fetal and postnatal development of the rat kidney. Kidney International. 53(1). 25–30. 34 indexed citations

Yoshida, Kazunori, Masahiro Kohzuki, David Casley, & Colin I. Johnston. (1998). Angiotensin-Converting Enzyme Inhibition and Salt in Experimental Myocardial Infarction. Journal of Cardiovascular Pharmacology. 32(3). 357–365. 7 indexed citations

Allen, Terri J., et al.. (1997). Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes. 46(1). 19–24. 50 indexed citations

Dean, Rachael, Rebecca A. Lew, Jia L. Zhuo, et al.. (1997). Localization of bradykinin B2 binding sites in rat kidney following chronic ACE inhibitor treatment. Kidney International. 52(5). 1261–1270. 17 indexed citations

10.

Dean, Rachael, Jia L. Zhuo, Daine Alcorn, David Casley, & Frederick A.O. Mendelsohn. (1996). CELLULAR LOCALIZATION OF ENDOTHELIN RECEPTOR SUBTYPES IN THE RAT KIDNEY FOLLOWING IN VITRO LABELLING. Clinical and Experimental Pharmacology and Physiology. 23(6-7). 524–531. 31 indexed citations

11.

Liu, James J., David Casley, Johann Wojta, et al.. (1993). Reduction of endothelin levels by the dihydropyridine calcium antagonist nisoldipine and a ??natural factor?? in cultured human endothelial cells. Journal of Hypertension. 11(9). 977–982. 11 indexed citations

12.

Fink, George, R. C. Dow, David Casley, et al.. (1992). Atrial natriuretic peptide (ANP) is a physiological inhibitor of adrenocorticotrophin (ACTH) secretion in the rat. The Journal of Physiology. 446. 1 indexed citations

13.

Nayler, Winifred G., et al.. (1992). Effect of Amlodipine Pretreatment on Ischaemia-Reperfusion-Induced Increase in Cardiac Endothelin-1 Binding Site Density. Journal of Cardiovascular Pharmacology. 20(3). 416–420. 9 indexed citations

14.

Kanazawa, Masayuki, David Casley, Edmund J. Sybertz, Martin F. Haslanger, & C. I. Johnston. (1992). Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 261(3). 1231–1237. 12 indexed citations

15.

Kohzuki, Masahiro, Colin I. Johnston, Keishi Abe, et al.. (1991). IN VITRO AUTORADIOGRAPHIC ENDOTHELIN‐1 BINDING SITES AND SARAFOTOXIN S6B BINDING SITES IN RAT TISSUES. Clinical and Experimental Pharmacology and Physiology. 18(7). 509–515. 17 indexed citations

16.

Fink, George, R. C. Dow, David Casley, et al.. (1991). ATRIAL NATRIURETIC PEPTIDE IS A PHYSIOLOGICAL INHIBITOR OF ACTH RELEASE: EVIDENCE FROM IMMUNONEUTRALIZATION IN VIVO. Journal of Endocrinology. 131(3). R9–R12. 50 indexed citations

17.

Liu, Jianjun, et al.. (1990). Solubilization and characterization of endothelin-1 receptors in rat cardiac tissue. Biochemical and Biophysical Research Communications. 166(1). 299–307. 11 indexed citations

18.

Kelly, Julian, Deborah Trinder, Paddy A. Phillips, et al.. (1990). Vasopressin antisense peptide interactions with the V1 receptor. Peptides. 11(4). 857–862. 10 indexed citations

19.

Liu, Jianjun, David Casley, & Winifred G. Nayler. (1989). Ischaemia causes externalization of endothelin-1 binding sites in rat cardiac membranes. Biochemical and Biophysical Research Communications. 164(3). 1220–1225. 55 indexed citations

20.

Nayler, W. G., et al.. (1989). Cyclosporine increases endothelin-1 binding site density in cardiac cell membranes. Biochemical and Biophysical Research Communications. 163(3). 1270–1274. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact